Loading publications…
The last 5 uploaded publications
A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods
Patrick W. Serruys, John A. Ormiston, Yoshinobu Onuma, Evelyn Regar, Nieves Gonzalo, Héctor M. García‐García, Koen Nieman, Nico Bruining, Cécile Dorange, Karine Miquel‐Hébert, Susan Veldhof, Mark Webster, Leif Thuesen, Dariusz Dudek (2009). A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. The Lancet, 373(9667), pp. 897-910, DOI: 10.1016/s0140-6736(09)60325-1.
Article146 days agoA bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial
John A. Ormiston, Patrick W. Serruys, Evelyn Regar, Dariusz Dudek, Leif Thuesen, Mark Webster, Yoshinobu Onuma, Héctor M. García‐García, Robert McGreevy, Susan Veldhof (2008). A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial. The Lancet, 371(9616), pp. 899-907, DOI: 10.1016/s0140-6736(08)60415-8.
Article146 days agoA bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial
Patrick W. Serruys, Bernard Chevalier, Dariusz Dudek, Ángel Cequier, Didier Carrié, Andrés Íñiguez, Marcello Dominici, René J. van der Schaaf, Michael Haude, Luc Wasungu, Susan Veldhof, Lei Peng, Peter Stæhr, Maik J. Grundeken, Yuki Ishibashi, Héctor M. García‐García, Yoshinobu Onuma (2014). A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial. The Lancet, 385(9962), pp. 43-54, DOI: 10.1016/s0140-6736(14)61455-0.
Article146 days agoEvaluation of the Second Generation of a Bioresorbable Everolimus-Eluting Vascular Scaffold for the Treatment of De Novo Coronary Artery Stenosis
Patrick W. Serruys, Yoshinobu Onuma, Dariusz Dudek, Pieter C. Smits, Jacques Koolen, Bernard Chevalier, Bernard De Bruyne, Leif Thuesen, Dougal McClean, Robert‐Jan van Geuns, Stephan Windecker, Robert Whitbourn, Ian T. Meredith, Cécile Dorange, Susan Veldhof, Karine Miquel Hebert, Krishnankutty Sudhir, Héctor M. García‐García, John A. Ormiston (2011). Evaluation of the Second Generation of a Bioresorbable Everolimus-Eluting Vascular Scaffold for the Treatment of De Novo Coronary Artery Stenosis. Journal of the American College of Cardiology, 58(15), pp. 1578-1588, DOI: 10.1016/j.jacc.2011.05.050.
Article146 days agoPercutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial
Daniel J.F.M. Thuijs, A. Pieter Kappetein, Patrick W. Serruys, Friedrich‐Wilhelm Mohr, Marie‐Claude Morice, Michael J. Mack, David R. Holmes, Nick Curzen, Piroze Davierwala, Thilo Noack, Milan Milojevic, Keith D. Dawkins, Bruno R. da Costa, Peter Jüni, Stuart J. Head, Filip Casselman, Bernard De Bruyne, Evald Høj Christiansen, Juan M. Ruiz-Nodar, Paul Vermeersch, Werner Schultz, Manel Sabaté, Giulio Guagliumi, Herko Grubitzsch, Karl Stangl, Olivier Darremont, Mohamed Bentala, Peter den Heijer, István Préda, Robert Stoler, Michael J. Mack, Tamás Szerafin, John K. Buckner, Myles S. Guber, Niels Verberkmoes, Ferdi Akca, Ted Feldman, Friedhelm Beyersdorf, Benny Drieghe, Keith G. Oldroyd, Geoff Berg, Anders Jeppsson, Kimberly Barber, Kevin Wolschleger, John Heiser, Pim van der Harst, Massimo A. Mariani, Hermann Reichenspurner, Christoffer Stark, Mika Laine, Paul C. Ho, John C. Chen, Richard Zelman, Phillip A. Horwitz, Andrzej Bochenek, Agata Krauze, Christina Grothusen, Dariusz Dudek, George P. Heyrich, Piroze Davierwala, Thilo Noack, Philippe Kolh, Victor Legrand, Pedro Coelho, Stephan Ensminger, Boris Nasseri, Richard Ingemansson, Göran Olivecrona, Javier Escaned, Reddy Guera, Sérgio Berti, Marie‐Claude Morice, Alaide Chieffo, M. Nicholas Burke, Michael Mooney, Alvise Spolaor, Christian Hagl, Michael Näbauer, Maarten J. Suttorp, Ronald A. Stine, Thomas McGarry, Scott Lucas, Knut Endresen, Andrew Taussig, Kevin Accola, Umberto Canosi, Iván Horváth, Louis Cannon, John D. Talbott, C W Akins, Robert S. Kramer, Michael Aschermann, William A. Killinger, Inga Narbute, David R. Holmes, Francesco Burzotta, Ad J.J.C. Bogers, Felix Zijlstra, Hélène Eltchaninoff, Jacques Berland (2019). Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial. The Lancet, 394(10206), pp. 1325-1334, DOI: 10.1016/s0140-6736(19)31997-x.
Article146 days ago